Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% CAM 0.330 −1.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% CAM 0.330 −1.5%

Healthcare

Page 90
  1. Dec 08, 2025 · 08:00 · AIDR

    Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta

    Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta

    01
  2. Dec 08, 2025 · 07:36 · APS

    Aptose releases tuspetinib triple drug therapy data

    Aptose releases tuspetinib triple drug therapy data

    02
  3. Dec 08, 2025 · 07:01 · CHER

    Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold

    Cheelcare Has a Record Month of Sales and Celebrates Milestone of 2,000 Companions Sold

    03
  4. Dec 08, 2025 · 07:01 · WELL

    WELL Subsidiary WELLSTAR Technologies Closes $62M Financing to Support Its Pre-Spinout Growth Strategy

    WELL Subsidiary WELLSTAR Technologies Closes $62M Financing to Support Its Pre-Spinout Growth Strategy

    04
  5. Dec 08, 2025 · 07:00 · ZYUS

    ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement

    ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement

    05
  6. Dec 08, 2025 · 06:00 · 4875

    MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

    MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

    06
  7. Dec 07, 2025 · 07:48 · ONCO

    Onco hires U.S. bank as capital market adviser

    Onco hires U.S. bank as capital market adviser

    07
  8. Dec 07, 2025 · 03:00 · ONCO

    Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

    Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

    08
  9. Dec 06, 2025 · 08:00 · APS

    Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

    Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

    09
  10. Dec 05, 2025 · 18:32 · VIVI

    Tempramed enters distribution partnership with Salomo

    Tempramed enters distribution partnership with Salomo

    10
  11. Dec 05, 2025 · 17:02 · VIVI

    TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

    TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg

    11
  12. Dec 05, 2025 · 16:31 · MYTC

    Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

    Correction to MyndTec Inc. Press Release Issued December 3, 2025 Regarding Non-Brokered Private Placement

    12
  13. Dec 05, 2025 · 14:26 · AFV

    Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction

    Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction

    13
  14. Dec 05, 2025 · 07:31 · VITA

    Vitalist Secures Facer for VitalOS

    Vitalist Secures Facer for VitalOS

    14
← Newer Older →